Results per Page:
Targeting the Integrator complex improves reactivation of HIV
From the Emerman Lab, Human Biology Division
‘Action and progress link our globe’
HVTN’s Dr. Daniel Driffin focused on hope in remarks at White House World AIDS Day event
Timing of ART administration for HIV is more important than we thought
From the Edlefsen and Frenkel Groups, Cancer Consortium
CAR T cell therapy targets HIV reservoirs to mitigate persistent HIV infection
From the Corey Lab, Vaccine and Infectious Disease Division
Win-win! A youth health training program could improve HIV service delivery in Sub-Saharan Africa
From the Duerr lab, Public Health Sciences Division
The unintended immune consequences of HIV treatments
From the Hladik Lab, Vaccine and Infectious Disease Division
CCR5 plays multiple roles in mucosal immunity
From the Prlic lab, Vaccine and Infectious Disease Division